Insider Transactions in Q3 2021 at Xtant Medical Holdings, Inc. (XTNT)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 15
2021
|
Greg Jensen Vice President, Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
156,250
+35.38%
|
-
|
|
Aug 15
2021
|
Matthew Rizzo Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,337
+41.45%
|
-
|
|
Aug 15
2021
|
Michael Eggenberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,337
+41.45%
|
-
|
|
Aug 15
2021
|
Robert Mc Namara Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,337
+26.94%
|
-
|
|
Aug 15
2021
|
Jeffrey J Peters Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,337
+26.8%
|
-
|
|
Aug 15
2021
|
John K Bakewell Director |
BUY
Grant, award, or other acquisition
|
Direct |
85,337
+26.8%
|
-
|
|
Aug 15
2021
|
Kevin D Brandt Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,169
-2.22%
|
$7,169
$1.2 P/Share
|
|
Aug 15
2021
|
Kevin D Brandt Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
162,109
+33.37%
|
-
|
|
Aug 15
2021
|
Orbimed Advisors LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
170,674
+41.45%
|
-
|
|
Jul 09
2021
|
Kevin D Brandt Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,800
-5.17%
|
$8,800
$1.74 P/Share
|